The Future of Schizophrenia Psychopharmacotherapy: More Antipsychotic Atypicality? Guess So!

Name: The Future of Schizophrenia Psychopharmacotherapy: More Antipsychotic Atypicality? Guess So!
SKU: 25837
Price: 30.00 USD
Availability: InStock

$30.00

Want a discount? Become a member by purchasing Psychopharmacology Bulletin Subscription - Individual!

Categories: Psychopharmacology Bulletin, VOL 53 No. 1 Articles 2023 Tags: Ahmed Naguy, Bibi Alamiri, brilaroxazine, emraclidine, evenamide, ralmitaront, roluperidone, Saxby Pridmore, schizophrenia

Description

Description

Review Article

The Future of Schizophrenia Psychopharmacotherapy: More Antipsychotic Atypicality? Guess So!

Ahmed Naguy, Saxby Pridmore, Bibi Alamiri

The Future of Schizophrenia Psychopharmacotherapy: More Antipsychotic Atypicality? Guess So!

Description

Review Article

Genetics of Schizophrenia: Recent Advances

Vicki L. Ellingrod, PharmD, BCPP: Leptin and Leptin Receptor Gene Polymorphisms and Increases in Body Mass Index (BMI) from Olanzapine Treatment in Persons with Schizophrenia

Agomelatine for Depression in Schizophrenia by Jochen Mutschler

Johannes Hamann, MD: How Long do Psychiatrists Wait for Response Before They Switch to Another Antipsychotic?

The Future of Schizophrenia Psychopharmacotherapy: More Antipsychotic Atypicality? Guess So!

Description

Review Article

Related products

Genetics of Schizophrenia: Recent Advances

Vicki L. Ellingrod, PharmD, BCPP: Leptin and Leptin Receptor Gene Polymorphisms and Increases in Body Mass Index (BMI) from Olanzapine Treatment in Persons with Schizophrenia

Agomelatine for Depression in Schizophrenia by Jochen Mutschler

Johannes Hamann, MD: How Long do Psychiatrists Wait for Response Before They Switch to Another Antipsychotic?